All posts tagged
Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic
Merck Outsources the Development of its Nanobody for Psoriasis
What are the Best Countries to Recruit Biotech Talents in 2017?
More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV
More News! Cevec moves into Zika, Ablynx’s Latest MAA, EMA in CPH?
Llama-inspired Nanobody Therapy for Psoriasis clears Phase I
An Antibody to reduce Hospitalizations of Children starts Phase IIb trials
UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan
Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie
Nanobody Phase II Results for Arthritis: Good but not good enough?
Llama Antibody Inhalation gets Positive Results for Respiratory Virus
Our Top 5 Articles on Biotech & Rare Disease
Labiotech UG, All Rights Reserved -
Send this to friend